idaptiq is an AI-native biostatistics automation platform for clinical trials: it automates the statistical analysis plans (SAP), SDTM and ADaM datasets, and TLFs required for FDA and other regulatory submissions, with its idaptlinq module linking deliverables so protocol amendments propagate automatically. Founded in 2026, the company pairs veteran biostatisticians with software engineers — its founders previously built Array Biostatistics (acquired by Allucent) and Ribbon Health (acquired by H1) — and serves biopharma and CRO customers on a GxP-compliant platform where patient data never passes through an LLM.
1
Round
1
Industry
5
Tags
Nov 2, 2026
Latest raise
Funding activity · 1 round
Nov 2, 2026
$2.8M
Seed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
